{
  "directed": true,
  "multigraph": true,
  "graph": {
    "pybel_version": "0.13.2-dev",
    "document_metadata": {
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved",
      "licenses": "CC BY 4.0",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "name": "Alpha-synuclein oligomers: a new hope ",
      "version": "1.0.0",
      "authors": "Esther Wollert",
      "description": ""
    },
    "namespace_url": {
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/mesh-names.belns",
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/chebi-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/hgnc-symbols.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/go-names.belns",
      "HBP": "https://raw.githubusercontent.com/pharmacome/terminology/785431732a26d6809b4162d98b95687d16404e63/export/hbp.belns"
    },
    "namespace_pattern": {},
    "namespaces_uncached": [],
    "annotation_url": {
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
    },
    "annotation_pattern": {},
    "annotation_list": {},
    "path": "snca/bengoa2017.bel"
  },
  "nodes": [
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "(-)-epigallocatechin 3-gallate",
      "id": "6ab1c80d3de724e6d924795da884f193d598624c7407acbe86dd59da673081130206c19bcf6637d2372ba76d86fdbe737a1dff9f7a9b685fb82284147388c222"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "calcium(2+)",
      "id": "4fb8648e4c5fea95cea6a46291d28175bba677d8b6fa8d607b1febef51c8370cbc1ff98d09312dc418ff31d04177d26f231d4f0a1a963f43fbc29cfb3269d3c9"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "reactive oxygen species",
      "id": "5da7879846ec42231f9176e97a7f14c4b573807576fa75be6e3acb71f391f25971e33d2f7fb886003ebd8020ab592e1424e2fc106f91213d546078dd09fabb65"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "curcumin",
      "id": "a784cb1e1965d09b2812ceaada10e172836399f6b72ec8154a36346d212255f49d8ae319b42578ea1c29fe7b4f04e3396e963011eb98b928bfd624dfd7fa8787"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "salubrinal",
      "id": "457881eba6833d5b6664d368417fb2aeeb44409089023dcba70fe5bc8cde8569c3ad606e71011e9cfc3a68cd45d47b3e95021152fbd11d3bc9fe443f4350c304"
    },
    {
      "function": "Abundance",
      "namespace": "GO",
      "name": "microtubule",
      "id": "0c753f37efe0eb149a47a1dd700eda093a03b462374275c68480b6aed3be0f81aa9793a179dfd97f8e0834f1fb9be4b4a6cff2165b176d9e8a8744f5e0d5bc2c"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "HBP00016",
      "id": "224ab9fa08008ca2f4eb57b049669ffcecdfdf9b93189cdd4014bfd3ec6dcfb4a3e19393339e329dc1deda84b1d5217b8f8119cab299dd2d1ae9c7dac7fabb5f"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "HBP00017",
      "id": "67d8e005cf6f7f86f11a2e6dccd1bf875213ceef268c7a0f79eb935668d46473a3ca56aa97b4664f93e8e03aa186e529d9e45750e306f0c906404e207b7aedf2"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "HBP00018",
      "id": "02687c6eeb46ccbcbec50069a9cfb1fa68f909b6e2561113168056b67bb0bf2ba792947c01184f651a07fba88c5a3be36308763e517d8df555da97bc1e2156aa"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "HBP00092",
      "id": "a0ac4e8d87297ef18b7f53bf350a743997c3cbbf0b257d8bd7ec913783e660e33597d2bb7ba467829254c261fabf3258f1a992dc2e6eaa75435492cbbbb1c042"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "HBP00093",
      "id": "40583f1741facba41ac9f3de18ebe0de8c4c07f3a19bdf18429bffb135fd6a3207e9a3b64c32f9f5547bcd6ac00f8697383aa1b78b9abe1493fb7bc23d5dd87b"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "HBP00094",
      "id": "3c29fbf76b79b175f7de84d58aca3f9cc47d8f9265b14618320d1b95cec0a4c9c50ff73f40faa66650b1d8de9427888811287694583ed42b66720e3f6539915c"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Cell Membrane",
      "id": "01ec7ffbcb8c9179057e9b0566861267a0a59f1b56f279101da5015908500b307bc7b168ef6d6540548d8fe99dd18a44e972e1682631a179a440ad4e5f662b4a"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Golgi Apparatus",
      "id": "15023fd7dc520e9f7d90ed3ec1377ce46afb06bc6122dc6d4f7fee5c96668164f10c6bb016f8a67b3f79d1cdc890c060663ca493e374303855b31ad2910a0187"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Astrocytes",
      "id": "fde64edccc2d2516ac85472bd1b91641459a78f34e06f497636f2c401c2df220b9a929108658f0d9c4b8091c3bb917ecf96b52133a312a439d8370e834a2ef91"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Kinesin",
      "id": "e0b5860aa8a6680103e27982b3a6ac2cabfb24cd338360586c07e8918ec6bbb2eb20fce39105e2ac0a12c90ba494694d4e2d588e60f10e13bb44d056b8257e0a"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Mitochondria",
      "id": "8239d19592a7e8cb8a527e24faaa0525a4e648d810d9bf5a43a163754e30e3c96fb63ce1c21e2a445871a5b231d04c1852723d5b756f0b7276343cc13d48e781"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "SNARE complex assembly",
      "id": "9506343118b89e3c2d0f6096737619c09ae10443020ba8824d5c042ed7464f007435e93f03b8eefcdc590601c7efaef863b3a8fac45866e006426f88ee882124"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "apoptotic process",
      "id": "1c5172472cbecf29eeb8e86a4cac2d13123fe572356f00e2f98302422560bbda2854e3b1f8fdf85396655393cf5ddb42e0db210c3d3fc146fa358cc8d0ed0254"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "axonal transport",
      "id": "05b46e2a47c4835f765deb7eb33b970b7abbb53b690b7881e2beda6bc739337253a12aaafa51ebf63ed9f7ad7f09bcd7f5ce4fda7373ed3f4f0eadedaf2c14d0"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "inflammatory response",
      "id": "422dfc2db00b1d942862470cbabe1e8312bf97b25050190db5ae19636adae95f4fa18c512574526825bd377b16c2278899435eb759e951ba850ad476e14f9900"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "microglial cell activation",
      "id": "9e9682b78aa06bbcb9dae35006f6da468e11928c000097001cd665b1bedf3c75ef887ecd7781ef3c545cafb3780cb7afabec9bfc70e14a48149d8adee8502981"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "synaptic vesicle transport",
      "id": "8b8d69e34abfbe32312eb0ab0f121d348adb58dfdcd7285c3984edcc6370f78c9195e09fe526096f94e4bd138017c0e0a3144c7cf780788a2fc7d38856b0a3d1"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "autophagy",
      "id": "f1a3202be460e565f65c1445ee061e99f63cc05f9ab70c5d4d8d93ba180d6a94f65cb8d1ac6c5ba53c0a4d2e153db32135e6a0bffcfdfd4d84e6727594a70b0a"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "HBP",
      "name": "HBP00037",
      "id": "1030498ceb2ae13f2056b7faab7ddafc87bfa958a8b4f2275f45d508c874310da9c097a2bfaa89632619e809898d1d0110c80eca7e58922718426199791a067c"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "Endoplasmic Reticulum Stress",
      "id": "89273f58f970a9467557f020ba5f5af7f8eb84045d0b1fb2eeba697d56475fcb2dae9019025a1d89fab2cba9466474067ed76af341294164c040dcb7b6e90507"
    },
    {
      "function": "Complex",
      "namespace": "GO",
      "name": "proteasome complex",
      "id": "5deb6bcfdcfa66f95c4979205b8144cf23a26c8da492c2d4b71750a7f8e440a3d40a37452d67ccbdccfba2bd5cea7bf1bbba3d66e18875bae3fd8abd8d3d68f4"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Abundance",
          "namespace": "GO",
          "name": "microtubule",
          "id": "0c753f37efe0eb149a47a1dd700eda093a03b462374275c68480b6aed3be0f81aa9793a179dfd97f8e0834f1fb9be4b4a6cff2165b176d9e8a8744f5e0d5bc2c"
        },
        {
          "function": "Abundance",
          "namespace": "MESH",
          "name": "Kinesin",
          "id": "e0b5860aa8a6680103e27982b3a6ac2cabfb24cd338360586c07e8918ec6bbb2eb20fce39105e2ac0a12c90ba494694d4e2d588e60f10e13bb44d056b8257e0a"
        }
      ],
      "id": "729993ccf92e3e5ccd2560b53ad69a0d0f6f84061fa3965c7e5a3551288df497093b4e67f3cd1c600b24dbb9f155db8fed8246921af89f521d1e69ed6b69b1fe"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Abundance",
          "namespace": "HBP",
          "name": "HBP00093",
          "id": "40583f1741facba41ac9f3de18ebe0de8c4c07f3a19bdf18429bffb135fd6a3207e9a3b64c32f9f5547bcd6ac00f8697383aa1b78b9abe1493fb7bc23d5dd87b"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "VAMP1",
          "id": "f866c8c3beb7dc9a3deceb4135a5856f9b31c4daefff479793aae0a6e88e32d15d6890378f21f748cd932c409148e7b7afe8e612a02fb4c2409e905fcb1fd455"
        }
      ],
      "id": "9654a00b9e99c13d44b0bca4181a039d6deaca2fa791fd27402d5173e9c9e698477d9e6dc60f0ee1183d9675a35e4c1aca73d775c95e45c1613353ba8b5a2a8b"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "HDAC6",
      "id": "c6e2cb3c91ba614ec9e19574656eba9d234344b755f57479d99a4d4ff77acc4917594446b9b19f9823e8a8a0d2d457d74b6f6a582d9f360f13df4136d902c7c3"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "LRRK2",
      "id": "f96ead302c9d5f0deee787cbc3ab3b9a683a4c41955ca6520d12263f2bfbc9810e87220fbe1c64675505d5e699f6e802c656ce2a11fb5936f0670423987e141e"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "LRRK2",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "p.Gly2019Ser"
        }
      ],
      "id": "09ee74ee2a3f69d927906657662555caabdffd619da7a6d21bf8499552c71e8639645a1f42dedaaaaa5a5f23b047a789e3a6e6222552b05bea22aff6b4de765b"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "PRKN",
      "id": "c129e31246d9b635f2d39f8a0d20e11d29724b9888bc1c35e5b5f5eb721f42a8ead8ccee052e21a3c178f79c19d2fecb3360bd35d0a89f449b2d05af14ae324f"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "PRKN",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "?"
        }
      ],
      "id": "18bad2008a5318b2ac88e39192c1cdc3930229cde4d1875cba179e0c144b7ee324191837819b0e6294790388cc7e202eca06b5776e5def8f36b099e366069eb1"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "SNCA",
      "id": "4345441d1f420dc0d830377737dba9467f21b1637ed3472a697534ce698f2566b780dd52cda47c96b782242b1bcfa70e9a6147fb3bb251d1f3e1e2a0bb7038f3"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "SNCA",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "p.Ala30Pro"
        }
      ],
      "id": "56ce8be3c490eafefc734158205e27bfcde01c5d160354345ad61607099ca26704f9f079559cf958aa16b1ae1fffafd552ddabf79ecf722d81d7b3ec047ff1be"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "SNCA",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "p.Ala53Glu"
        }
      ],
      "id": "0d233111c4dae7c6056cc60649172e409e279dbcbd11e48431b9ce42bce5324e5b2295d2f82d7485a5b512c56645c4beaa7536a4fbed666bc7954f8d479e2885"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "SNCA",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "p.Ala53Thr"
        }
      ],
      "id": "d2068443e7a690d5d02ecf646516124d655e615c8f4a7c320cad114af8b6cb752bcdb98e8973c053690af90c8cb72d8d4211d4f8f1314c79c1aab0bbd385c692"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "SNCA",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "p.Glu46Lys"
        }
      ],
      "id": "99c3c9b0570d65ca12c2d36d1e2aeeefedf4f40a296686aec6d52be37a2ea6b4917239dd3ced7341e83742aeefe3170916f8b0fb876378a0b959b394798d64b6"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "SNCA",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "p.Gly51Asp"
        }
      ],
      "id": "c16c0366121175c5181c6386d1999a0e1c38c489590b03be38c892975db2a4c7715522ebda43545cb5eb7710b046fa9a6698ed1f2301172b1427051a9bcc49ac"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "SNCA",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "p.His50Gln"
        }
      ],
      "id": "d092739935db44b23cca1da78eafc19242be4ac684ac904de8184eafe23490dc65e533b306826e9e80b3263796879c3630190bcbf6212d6f0e403539b9531cdf"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "TFEB",
      "id": "d2586deea41500a6ea7755a94475bef3e256337b994748bb58034e8a43261cfea2cf38bc85241d08d9e06bdfc15b92df32297bceb6a3bf8848c3f2d6878b030b"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "TLR2",
      "id": "0f6907265dc069929af65d69b22bf45e32c22dae9b37b9e2a46bfe52b79bc136835507187a3f3e80a7062f116acfc44532ab9bc11456d8ac5fc143b327274b25"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "USP19",
      "id": "9e2f6022d4589721d0683b2ed23f6867213b72915c7b662824d0597d651ba4d266ec8793e753799e2af1916efaf66f6c969fc717ace6884efee04dfa1625ca6d"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "VAMP1",
      "id": "f866c8c3beb7dc9a3deceb4135a5856f9b31c4daefff479793aae0a6e88e32d15d6890378f21f748cd932c409148e7b7afe8e612a02fb4c2409e905fcb1fd455"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Lewy Body Disease",
      "id": "96e3a681a3c1aae0a3a2b158907153fc5e976e52d355cfecb0af2b5ab767bda982ed8c11b147dcfb04800986cc50e61613c751e724d8259e7863ae31adfd78f1"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Neurodegenerative Diseases",
      "id": "95863a6d11beb3bd993523e1c8c7e210d281b0c092553f6a4cf27dd3ecf2fa51b49c5056b8aed6f7ac7c82f99101c34bc9fc0afc3dce117fe011d159ba9e4c89"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Parkinson Disease",
      "id": "d7f039170f83b3fcc27595412f3b0352cd1fe95f8481a2b1144ce311ac81bb5f0087a0a7e682f498d193e00b8e8fb29908a6e0b8e23da5ef349aeeb4723b9be0"
    }
  ],
  "links": [
    {
      "line": 38,
      "relation": "association",
      "evidence": "Over the past two decades, the pre-synaptic protein alphasynuclein (a-syn) has been irrefutably tied to the neurodegenerative disorder Parkinson’s disease.",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 34,
      "target": 47,
      "key": "c91387987265f251e00ef9ee912b059a071f54401aabdc6213729b0f022ecb38af7918d873e388df6a2ae7e130ebe83c9e106c0915a5a40bfd068179ffa1a1fa"
    },
    {
      "relation": "hasVariant",
      "source": 34,
      "target": 37,
      "key": "be326115b03b23c8f9535c21a847d21c9d71e9ca0a6e59ec5908fdafce0eaeeec33010beead981cf64164710a885bfd84590f8605663c0c087fcfebbf7ab6580"
    },
    {
      "relation": "hasVariant",
      "source": 34,
      "target": 35,
      "key": "d7fd63af4e3f7cfae7a2b90e0640eb9e32d7d438c80a40b935d1b4c063e700a98f91942bafcfb9e978093c0c678b1875a13dc8e6ce459a7df6f0dedb0be84748"
    },
    {
      "relation": "hasVariant",
      "source": 34,
      "target": 38,
      "key": "aa1cd1b1fde5819fffb3bd274592ccce1d2ee7acd6a99c98ef1fad0adeda7dc633412e77345238b3db54cf10af5d5a356d6bf5c157e1dc23744b18a0f7ff7345"
    },
    {
      "relation": "hasVariant",
      "source": 34,
      "target": 40,
      "key": "d3f6784550109a7129f4c01b5a89f80a55d77d327234c87051f26347b83a04d196f5e486f9a99366c477cd5c4853be14aa7417fc60d0b8458c555e779797c61d"
    },
    {
      "relation": "hasVariant",
      "source": 34,
      "target": 39,
      "key": "b4f96c3cc830cb9e0e81f63db348b1b62a27c714fe45a603cb3f6ca7cbe7eaedabd54a59877326d464b92464037e3baf2373ef606d0af3a165ac1a29daa76c76"
    },
    {
      "relation": "hasVariant",
      "source": 34,
      "target": 36,
      "key": "c5cc4105fbe412fa9cad8c8e877d365621e80493f903f43c2bcbc85f349449cc556534f5e59ca1c2aeab80ac1ba5a6fc6efaffb77a78f5a91a760c8dc3dbb2e6"
    },
    {
      "line": 38,
      "relation": "association",
      "evidence": "Over the past two decades, the pre-synaptic protein alphasynuclein (a-syn) has been irrefutably tied to the neurodegenerative disorder Parkinson’s disease.",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 47,
      "target": 34,
      "key": "3787278b91bd2e557ee96e5e7fd389c872d00679a66ba63221dcd51b4fb6939d010eb5fece52a2bc1f63dc64203fa996f63e5195dbadf6f340b4f235a452e06d"
    },
    {
      "line": 194,
      "relation": "positiveCorrelation",
      "evidence": "Elevated levels of a-syn oligomers were found in PD patients compared to controls or AD patients in brain homogenate, CSF and serum.",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true,
          "Brain": true,
          "Serum": true
        }
      },
      "source": 47,
      "target": 10,
      "key": "e9fca460863f3f0107f3965e4c21c71b37deebb2fd3d4f53512c7101412ede857aef46f529800dfef77fd53978124b82f3be5c8914e13c48c9c6de676e7f6d92"
    },
    {
      "line": 44,
      "relation": "increases",
      "evidence": "the point mutation in SNCA (A53T) was demonstrated to cause autosomal dominant Parkinson’s disease [126] and several other point mutations (A30P, E46K, H50Q, G51D and A53E) have since been shown to cause familial forms of Parkinson’s disease and dementia with Lewy bodies (DLB) [4, 79, 84, 119, 129, 167].",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 37,
      "target": 47,
      "key": "e1c61da3dff2a292490e649ebecc373ecd02814d9f7cb3d12c16d848db824814f0bbe964fdc1cf84fa5963f89bf59cb2a3748d13b32228ee98137092d5e611d7"
    },
    {
      "line": 45,
      "relation": "increases",
      "evidence": "the point mutation in SNCA (A53T) was demonstrated to cause autosomal dominant Parkinson’s disease [126] and several other point mutations (A30P, E46K, H50Q, G51D and A53E) have since been shown to cause familial forms of Parkinson’s disease and dementia with Lewy bodies (DLB) [4, 79, 84, 119, 129, 167].",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 35,
      "target": 47,
      "key": "4a396c61f6812a2c01d47da3653dd8933f16584d0bf5b0f2b177906af07dc561313d1bfe4639e89bf982172cd81a2012f95d155b180b88abed9633e0bd0f77e3"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "the point mutation in SNCA (A53T) was demonstrated to cause autosomal dominant Parkinson’s disease [126] and several other point mutations (A30P, E46K, H50Q, G51D and A53E) have since been shown to cause familial forms of Parkinson’s disease and dementia with Lewy bodies (DLB) [4, 79, 84, 119, 129, 167].",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 35,
      "target": 45,
      "key": "41d57aafc0860b32903972ec3927483575b3537cf49dd35a8a1efad084bff88032d19143d5355a7d72e97c375356328074fc7ff132f50c2f2d12277342c770b1"
    },
    {
      "line": 47,
      "relation": "increases",
      "evidence": "the point mutation in SNCA (A53T) was demonstrated to cause autosomal dominant Parkinson’s disease [126] and several other point mutations (A30P, E46K, H50Q, G51D and A53E) have since been shown to cause familial forms of Parkinson’s disease and dementia with Lewy bodies (DLB) [4, 79, 84, 119, 129, 167].",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 38,
      "target": 47,
      "key": "ab843f6c953bf063d7891318006e3a2d1b93e932b3f70f244034432055c61b6d42075bf22725b7a4e77e7268be5d88f6ef3c86627bb7914e108e0a30b2c2f888"
    },
    {
      "line": 49,
      "relation": "increases",
      "evidence": "the point mutation in SNCA (A53T) was demonstrated to cause autosomal dominant Parkinson’s disease [126] and several other point mutations (A30P, E46K, H50Q, G51D and A53E) have since been shown to cause familial forms of Parkinson’s disease and dementia with Lewy bodies (DLB) [4, 79, 84, 119, 129, 167].",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 40,
      "target": 47,
      "key": "696953ecc2673ed0af592001d88571cb1eb5f64f2cf1951cce3f8d8acfdd238dbf474401cf25198972b35512515a8ff18d33f09807ac7760ce15a8dcbe99a2bb"
    },
    {
      "line": 51,
      "relation": "increases",
      "evidence": "the point mutation in SNCA (A53T) was demonstrated to cause autosomal dominant Parkinson’s disease [126] and several other point mutations (A30P, E46K, H50Q, G51D and A53E) have since been shown to cause familial forms of Parkinson’s disease and dementia with Lewy bodies (DLB) [4, 79, 84, 119, 129, 167].",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 39,
      "target": 47,
      "key": "6173a17a8863be33f180e55864b372af757aa4245752e444631124af7daba49f6dd22800101b5163d4a9802c8a7dd0069509367cbd435aedd289ee66e01ad736"
    },
    {
      "line": 53,
      "relation": "increases",
      "evidence": "the point mutation in SNCA (A53T) was demonstrated to cause autosomal dominant Parkinson’s disease [126] and several other point mutations (A30P, E46K, H50Q, G51D and A53E) have since been shown to cause familial forms of Parkinson’s disease and dementia with Lewy bodies (DLB) [4, 79, 84, 119, 129, 167].",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 36,
      "target": 47,
      "key": "eaa88491cbb10ff4dc8427a3fc4ebfe33a1fde14b0c932893fd96f6f8a485f0e47b3e338350388e4cbbd85bb05f323d729545f38adcd4dafbad76dc853a60185"
    },
    {
      "line": 59,
      "relation": "increases",
      "evidence": "Not only did this discovery draw attention to aggregated forms of a-syn as mediators of Parkinson’s disease pathogenesis, but also opened the door to the use of a-syn detection techniques for diagnosis and staging.",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 6,
      "target": 47,
      "key": "36425a86bb4b65166ec86efba1944492b09cf33c121e1005a0402ca9290d8b4cf4ce11522fd7a1a3ae552e1064077911f2de2faa1a6c0ae77a271450e8086691"
    },
    {
      "line": 64,
      "relation": "increases",
      "evidence": ". Multiple lines of evidence now suggest that oligomeric species of a-syn, which are thought to precede the fibrillar aggregates found in Lewy bodies, are the culprits for neuronal degeneration in Parkinson’s disease",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 10,
      "target": 47,
      "key": "390ce544d99288213cf00c89efcc8b43905ee10a7ac669282352d49a0bef3c4a4b7025561efbeac1578290499e79c2efe1dc339764ea93ba859cfc49e4267197"
    },
    {
      "line": 189,
      "relation": "biomarkerFor",
      "evidence": " Oligomeric detection may have uses as a diagnostic biomarker, as a biomarker of the progression of the disease, and in the future, perhaps as an index of response to novel therapies. ",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "source": 10,
      "target": 47,
      "key": "4c6996f05f57f65891a7e8a91718ae48118117d8eef24d3391ea25fe59b40a99fcc8a884d1f6f11f1babf9126be709d4b259f05a82424b6ac511fb2caab09701"
    },
    {
      "line": 194,
      "relation": "positiveCorrelation",
      "evidence": "Elevated levels of a-syn oligomers were found in PD patients compared to controls or AD patients in brain homogenate, CSF and serum.",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true,
          "Brain": true,
          "Serum": true
        }
      },
      "source": 10,
      "target": 47,
      "key": "3107e8fe5c828f2affb308b78870e12f86593e070a45289cf56f7ac1ec712aed41e14ed2491fec508f1c3e3df66529d76338cf6272b03a4a6fd3e7dec45b5191"
    },
    {
      "line": 65,
      "relation": "increases",
      "evidence": ". Multiple lines of evidence now suggest that oligomeric species of a-syn, which are thought to precede the fibrillar aggregates found in Lewy bodies, are the culprits for neuronal degeneration in Parkinson’s disease",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 10,
      "target": 9,
      "key": "0dd05d5fdb2bcbdfc2b44709590fda7931ace6be4a6a383e5a0c4b4e8771874917977b6f6dcd9610655dd925f05dee916c82ab056849eaed2cb6dba06efd5725"
    },
    {
      "line": 76,
      "relation": "increases",
      "evidence": " In vitro formed a-syn oligomers ectopically applied to cell cultures or formed due to overexpression of a-syn induce cell death [20, 30, 109, 149], which has been recapitulated in vivo in several studies.",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 10,
      "target": 18,
      "key": "9b6e00ab3c9ac89d2a043693136fcc75ead6ab6250849c4878b962cb16c19c2ee58ca4c5a932f4a20f133bb22ed755a6f5a8579a027b3fde60c37c8b809e24a6"
    },
    {
      "line": 82,
      "relation": "increases",
      "evidence": " In contrast, a-syn 30–110 that forms fibrils at a fast rate, did not display toxicity, indicating that oligomers are indeed the toxic species leading to TH-neuron loss in vivo [162].",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Cell": {
          "neuron": true
        }
      },
      "source": 10,
      "target": 18,
      "key": "87a13d967c3a5a8d7f52f332452153a1de13f736150546f51fa74d1b518d22c3bdddcbbd9bfbf532fc3b291712136f7ddc7b18bb2ea834e25e3425f0563e0726"
    },
    {
      "line": 89,
      "relation": "decreases",
      "evidence": "In 2014 Plotegher et al. showed that mitochondrial morphology is disrupted by a-syn oligomers, which cause fragmentation of these organelles in vitro in SH-SY5Y cells [124]. ",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 10,
      "target": 16,
      "key": "032ce203a5da44f8d5b19308afac196cbfe76c95cbf058f552e783e0ba70cbf45f2ccc52cd0020f7635b7130ebd81b2bebcb220d0587cee7ed5b28a882ed3518"
    },
    {
      "line": 98,
      "relation": "increases",
      "evidence": "All these results show that a-syn oligomers are implicated in mitochondrial dysfunction across different models.",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 10,
      "target": 24,
      "key": "40bf9b8180d905903970250e4fb52f595519f44da76dc6065ba485f53c1e75f620b61ada5e4ef14b55cdf8fe020bd695ade8a88fe5c3c849cf6172064ce0d018"
    },
    {
      "line": 103,
      "relation": "increases",
      "evidence": "Accumulation of oligomers has been demonstrated in a transgenic mouse overexpressing A53T a-syn and in Parkinson’s disease brain tissue, resulting in chronic ER stress and impaired ER protein quality control [25].",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 10,
      "target": 25,
      "key": "86760cee387ae5f7d0b48f5ac7b3c3bf3a092e643b803eeb731eff32c547ccf5948e005edc5cde0dcd9cc13287c359647adc9ed02a226cc0ccdd6d892646d95f"
    },
    {
      "line": 114,
      "relation": "decreases",
      "evidence": " This can be inhibited by a-syn oligomers: oligomers were shown to inhibit proteasomal activity, which was blocked by addition of antibodies that neutralized the interaction [87]. ",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Endoplasmic Reticulum": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 10,
      "target": 26,
      "key": "51db9e988b503a40a741f76d25e47df1af64996e6c32e0c8e9c581f94db897b9bdd6d5eb28dc4fdc90230ef3e3fb480f8eb49802515cdc907ff02db5660aad59"
    },
    {
      "line": 131,
      "relation": "increases",
      "evidence": " However, in a different report, oligomers were shown to activate proinflammatory signals in microglial cells in vitro and in vivo, and this was prevented by addition of a MAP kinase inhibitor [161].",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "source": 10,
      "target": 21,
      "key": "e55f3173fd9cb6106fb02ff2af9561c1ce9952b1cf0a67c6cd312c0eb5522a1288287c0e48743b0774e21b14acc18d284033720b525b91137005a1b69966c9e8"
    },
    {
      "line": 136,
      "relation": "increases",
      "evidence": " Kim et al. demonstrated that a-syn oligomers lead to microglial inflammatory responses via TLR2 activation [74].",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "source": 10,
      "target": 20,
      "key": "b4db8a33898356e8aa9d9936e531b42c926ca98154aa4fb0159d53d817cbbe9b85bb49f19aa4eaa75cdc0f1a8fa0ed22f62cc619b85908ef06af4a3dbae69083"
    },
    {
      "line": 137,
      "relation": "increases",
      "evidence": " Kim et al. demonstrated that a-syn oligomers lead to microglial inflammatory responses via TLR2 activation [74].",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 10,
      "target": 42,
      "key": "713c5f44d519900300183669129987b13c09c7f2edfaddb411ca3f35b05e4cda32494a8b33accb5843d67196e3e204aa84e10de0eb68d5faa1c29a7fc2016b02"
    },
    {
      "line": 142,
      "relation": "increases",
      "evidence": " Another report by Zhang and collaborators also highlighted glial activation and production of reactive oxygen species in response to oligomer-like preparations of aggregated a-syn [168]. ",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "source": 10,
      "target": 2,
      "key": "64867b38f8e42d28903691c9be016744e513dfdfffc8553cb78f70e617cb76c1bba5a2541c4e1bdc6e9e5840ac992a6c5998ef6bc3efa85c77f6d707c8dd7fdb"
    },
    {
      "line": 147,
      "relation": "decreases",
      "evidence": "A-syn oligomers can stabilize membrane defects accelerating membrane damage [19] and can alter membrane properties such as input resistance reducing neuronal excitability [72]",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "source": 10,
      "target": 12,
      "key": "ca5d1ff07b1ae5985a53c81f4d329eeba73cc2019b8b38506614389b47cfa2c45f28fe7a4c4d070a705838a3a8d0dd8053cac03738736be293a7b5f6a4ae1973"
    },
    {
      "line": 152,
      "relation": "increases",
      "evidence": "Dysfunctional membranes can also have an important impact on calcium homeostasis; some types of oligomers can lead to a cytotoxic calcium influx presumably by building pore-like structures [30]. ",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GO",
            "name": "extracellular space"
          },
          "toLoc": {
            "namespace": "GO",
            "name": "intracellular part"
          }
        }
      },
      "source": 10,
      "target": 1,
      "key": "641e00e72ace7ee257cbf302e5fbba29f8526ced4cf14802e738afb1901feb993d95c035e0913f8f29cb06956b4855d11e8479ffa0fbb3dfbfb2f4d050f3360b"
    },
    {
      "line": 173,
      "relation": "decreases",
      "evidence": "The trafficking of synaptic vesicles may also be negatively impacted by a-syn oligomers, which have been shown to decrease axonal transport by decreasing microtubule stability and impairing the interaction between kinesin and microtubules [128], as well as inhibiting tubulin polymerisation [20]. ",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "source": 10,
      "target": 22,
      "key": "738c5a801d20e5beb77007f25cc05c93a2983ed36edce8d132be86e8c0bb8bcb61665990e09bfe6f95e937453fa8cfa98bb29e309b97f79743a071e72a9f5fcc"
    },
    {
      "line": 174,
      "relation": "decreases",
      "evidence": "The trafficking of synaptic vesicles may also be negatively impacted by a-syn oligomers, which have been shown to decrease axonal transport by decreasing microtubule stability and impairing the interaction between kinesin and microtubules [128], as well as inhibiting tubulin polymerisation [20]. ",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "source": 10,
      "target": 19,
      "key": "5dc0235cc61871219e3b38c1f066f741705a553787a2d5d4c6a6ef4f7c1ca9bb99cc100de89a648202ce5914b29c36b89ff4509b2faf15c9e51befca3d7d8dbd"
    },
    {
      "line": 175,
      "relation": "decreases",
      "evidence": "The trafficking of synaptic vesicles may also be negatively impacted by a-syn oligomers, which have been shown to decrease axonal transport by decreasing microtubule stability and impairing the interaction between kinesin and microtubules [128], as well as inhibiting tubulin polymerisation [20]. ",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "source": 10,
      "target": 27,
      "key": "36ecdd3bbfb536f876483b4460172a5b7c81a60662244c2dc5557a2ee2288f8c1f799366c4724bce195ad286c6c8ee52f0ac55bda5015c1355e4dbdb142da759"
    },
    {
      "line": 179,
      "relation": "decreases",
      "evidence": "Golgi fragmentation has also been observed as a result of oligomers formed by over-expression of a-syn in COS-7 cells [55].",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "source": 10,
      "target": 13,
      "key": "d532c239e9c94bb18deb8ca475b0179c1e82beac3d9407ada56a391f672972346520bdc62252a4685495233aadf959024253155809f18475c86e12c7c76f9882"
    },
    {
      "line": 83,
      "relation": "causesNoChange",
      "evidence": " In contrast, a-syn 30–110 that forms fibrils at a fast rate, did not display toxicity, indicating that oligomers are indeed the toxic species leading to TH-neuron loss in vivo [162].",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Cell": {
          "neuron": true
        }
      },
      "source": 9,
      "target": 18,
      "key": "71372c4587d6a1c72de08757720dcd8c3b9c57434d67781c6a86b8d44de663ec79b2b87df0be7942704ff29df4f6d0e0664b74bcc28653ae31a1851066a8fb29"
    },
    {
      "line": 125,
      "relation": "increases",
      "evidence": " a report by Hoffmann et al. showed that fibrillar a-syn induced a more pronounced inflammatory response in microglial cells [61].",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "source": 9,
      "target": 20,
      "key": "b7af51873d89a27c9799b6d3d51801d6fe3270a447f14e35f3f05212bc3a5a94618d086a10243195b03ed220abbc765c41accf7bbcb2f20d05325a2b752b6e09"
    },
    {
      "line": 126,
      "relation": "increases",
      "evidence": " a report by Hoffmann et al. showed that fibrillar a-syn induced a more pronounced inflammatory response in microglial cells [61].",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "source": 9,
      "target": 21,
      "key": "ec015c7569e5a5874fec4be6b48e8fd0235a24c8a77d494c5ce265e6b48f921689a61d8fe3828177e194bc3481930eb0f12df0f70d20f116b837eb477991ced1"
    },
    {
      "line": 70,
      "relation": "increases",
      "evidence": " Finally, Parkinson’s disease patients carrying familial mutations in the parkin gene, and some of those with the LRRK2 G2019S mutation, show neuronal degeneration in the absence of Lewy body formation [28, 50]. ",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 33,
      "target": 46,
      "key": "daede0a0a1f1f64674f1767ef05dc7f339f88eeffb52eb2ad6aa829606e5e6038cf1956cc0575ff818553943c0fc8f4855d243a6669cf0fff4162bac182711b7"
    },
    {
      "relation": "hasVariant",
      "source": 32,
      "target": 33,
      "key": "10487a8d22b323a87b2ef92474948fe9cbbd3497ae38566976f3685b17a3f09a26f540d1004db223ccacd9eef7e6d00a24383486bf7c3f9af7c6e962c6c86f2c"
    },
    {
      "line": 71,
      "relation": "increases",
      "evidence": " Finally, Parkinson’s disease patients carrying familial mutations in the parkin gene, and some of those with the LRRK2 G2019S mutation, show neuronal degeneration in the absence of Lewy body formation [28, 50]. ",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "source": 31,
      "target": 46,
      "key": "f3fca68f27e5d16b613cf1a09ff3bef20811ff527a909500907db7cfb00d46710f324c7e00340762a4028961cc5c16b9109fb701710a600b45ec15be0614646e"
    },
    {
      "relation": "hasVariant",
      "source": 30,
      "target": 31,
      "key": "99c77f525143a54c34cd284711ced224797205a7c349bb13a00c2cd3202979f2d775f98ae2cd4eb4dd6e6e66e969b41335cc987dc70526200b480e8b3da7c074"
    },
    {
      "line": 94,
      "relation": "increases",
      "evidence": " Interestingly, it was very recently reported that astrocytes take up a-syn oligomers and degrade it via the lysosomal pathway, but this pathway can become saturated leading to mitochondrial fragmentation [89]. ",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 14,
      "target": 10,
      "key": "7e57cb60532798ae8d2220eafa70bf3827dd3b1eefceea50e19173afecef7d332409557c7505a77e132fcd57e8d05a6afd1de4cdd6e1a89960440404e1bf15e6"
    },
    {
      "line": 107,
      "relation": "decreases",
      "evidence": "furthermore, treatment with salubrinal, which alleviates ER stress, reduced oligomeric accumulation in the ER.",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 4,
      "target": 25,
      "key": "11b013466448366552cbe1c5203f3cc8c208ac4d4c2135f0bc6c3a0ab004a2ac5e27cf70edc0d458b98082178a39fb47b5455e723433160dde89e9a8b6d24381"
    },
    {
      "line": 109,
      "relation": "decreases",
      "evidence": "furthermore, treatment with salubrinal, which alleviates ER stress, reduced oligomeric accumulation in the ER.",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Endoplasmic Reticulum": true
        }
      },
      "source": 4,
      "target": 10,
      "key": "457dbbc19691131f64cf3cccce3949449b33eb144ea40c560a24a9677118000a6170909a0c34252b766dbe345b3f0f46b2bb3704201505377768b39a4a6ecdd2"
    },
    {
      "line": 120,
      "relation": "decreases",
      "evidence": "Finally, inhibition of histone deacetylase 6 (HDAC6), which was previously shown to be involved in the response to cytotoxic ubiquitinated aggregates, increased the oligomeric content in vitro, while overexpression of HDAC6 produced the opposite effect [36]. ",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Endoplasmic Reticulum": true
        }
      },
      "source": 29,
      "target": 10,
      "key": "9b065fb16f2e4823ecddad4a0dc3ba3d709aae0579f230bf40f55f6c1e744233505a8afb755b38a73fd891dd216a981f099118622253590429385923b9b53f41"
    },
    {
      "line": 157,
      "relation": "increases",
      "evidence": "a-syn accumulation has been linked to autophagic and lysosomal dysfunction, which may in turn lead to a-syn aggregation and production of more detrimental oligomers. ",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "source": 23,
      "target": 10,
      "key": "7a53c368f4283b2d9b0e448ce8e4ad47cb2577637804e3c99b8606da39378c33b606a4c12b9a1cd8aa7fae03d36e3017a07ccf90065de42a9123eff7b344ad1f"
    },
    {
      "line": 162,
      "relation": "decreases",
      "evidence": "Accordingly, overexpression of transcription factor EB (TFEB) was shown to correct lysosomal defects induced by the viral overexpression of a-syn and to downregulate the accumulation of oligomers in vivo [32]. ",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "source": 41,
      "target": 10,
      "key": "0fcbe4ad35f82b2a283b303c0c24e5c8980b9691ef65ec892b36a4885784f2500ecbd1e7f0a986f557b79de56ab6106ed1e8486c055a4ff48b9e88fa44d45303"
    },
    {
      "relation": "hasComponent",
      "source": 28,
      "target": 10,
      "key": "360672937f038aa53a047a29de256aeca72fcf1e5f09673c51480d12fbebbf062dcb152d2060ba984e775e4628c790f244cad212d115557404863111c958e839"
    },
    {
      "relation": "hasComponent",
      "source": 28,
      "target": 44,
      "key": "252f60f800681223106285656185aa70aad14466a279099dc6884665a8d73fb1da10372eef0c74ba8eb9e61dbfb33baef1657a6ebe57bc3e943245f413577ff9"
    },
    {
      "line": 167,
      "relation": "decreases",
      "evidence": " First, a-syn oligomers bind synaptobrevin, a component of the SNARE complex required for synaptic vesicle fusion, and prevent the formation of the SNARE complex [23]. ",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "source": 28,
      "target": 17,
      "key": "2e2bab295a15bd2035a1086143affee2dd5eb88acb176d95f148e5cf615177c8e8f316277db27403748c856e31a0362e46dc395b2f6c256b99d77aaf75e9b832"
    },
    {
      "relation": "hasComponent",
      "source": 27,
      "target": 5,
      "key": "12c81f586776542e89b325cf4249de0b20e376f60910d0fd2a80e6676263122e6b6371557ed3e6501f0c6e6852c9f37c8a7e9cf8296f99971c38a189db1578ef"
    },
    {
      "relation": "hasComponent",
      "source": 27,
      "target": 15,
      "key": "346fad8d878375e6fa818413431c835369be31f71b0da9659e94bcff572ca482e6ce31469d0ba8b887494fc1c23030d5482950b59dcec88972670b7e4302bfc9"
    },
    {
      "line": 184,
      "relation": "increases",
      "evidence": "USP19 promoted the secretion of a-syn, suggesting that MAPS is an unconventional secretion pathway utilized by a-syn, particularly under conditions of proteasomal impairment, which has been repeatedly linked to Parkinson’s disease. ",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "bel",
            "name": "intracellular"
          },
          "toLoc": {
            "namespace": "bel",
            "name": "extracellular space"
          }
        }
      },
      "source": 43,
      "target": 34,
      "key": "a4ced91192622f07363d63f70576b22326b3dfd8455d09d86d082746ef887abcf79385400ac6ebf545cd8587121897e1d6ba969507c0a598d3a9ff1a063c7ef9"
    },
    {
      "line": 198,
      "relation": "decreases",
      "evidence": " In vitro studies have shown that curcumin inhibited the formation of fibrils and disaggregated amyloid-beta and a-syn [112, 114, 155].",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true,
          "Brain": true,
          "Serum": true
        }
      },
      "source": 3,
      "target": 9,
      "key": "b11a73ac526f67034e326e3d1fcaaafc59a4da90de8af9835769a7f84afbea594c953d914dbdf7c1e215c49f75f4d22344508b53e11a22e078a1cc92ccb0d326"
    },
    {
      "line": 199,
      "relation": "decreases",
      "evidence": " In vitro studies have shown that curcumin inhibited the formation of fibrils and disaggregated amyloid-beta and a-syn [112, 114, 155].",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true,
          "Brain": true,
          "Serum": true
        }
      },
      "source": 3,
      "target": 6,
      "key": "6bc0936113167b462ab59bdc4a25de123d396f0709051998f455fa0885b58ec8c8320b979e02c739490d3b16ed52136d270af875e24ad634f9877448c3a5870f"
    },
    {
      "line": 200,
      "relation": "decreases",
      "evidence": " In vitro studies have shown that curcumin inhibited the formation of fibrils and disaggregated amyloid-beta and a-syn [112, 114, 155].",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true,
          "Brain": true,
          "Serum": true
        }
      },
      "source": 3,
      "target": 8,
      "key": "c419dc2520fef3321489819e39c1b2bbe9ebca5ab91cf884ccf6b075efb6c7e6c63b27036a0e2250296bdbc2b80d0bf289f61f739dc2f118298d0fdc4fa25912"
    },
    {
      "line": 206,
      "relation": "decreases",
      "evidence": "Epigallocatechin-3-gallate (EGCG), a small molecule that been shown to inhibit the aggregation of several amyloidogenic proteins such as a-syn, amyloid-beta and huntingtin [9, 37, 38, 105] binds to unfolded native amyloid-beta and a-syn and promotes the formation of nontoxic oligomers that do not convert into amyloid fibrils [37]. ",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true,
          "Brain": true,
          "Serum": true
        }
      },
      "source": 0,
      "target": 6,
      "key": "955186362b4c862293a27f930ad61a30e57c2a6b838686f19fd7261087ef795bf74eeb088c969c4f53c834a4f010b8cde06e74c1746a0023f4b79e2fe29bfc76"
    },
    {
      "line": 207,
      "relation": "decreases",
      "evidence": "Epigallocatechin-3-gallate (EGCG), a small molecule that been shown to inhibit the aggregation of several amyloidogenic proteins such as a-syn, amyloid-beta and huntingtin [9, 37, 38, 105] binds to unfolded native amyloid-beta and a-syn and promotes the formation of nontoxic oligomers that do not convert into amyloid fibrils [37]. ",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true,
          "Brain": true,
          "Serum": true
        }
      },
      "source": 0,
      "target": 8,
      "key": "168bc1efa4199c9170c08990c802f4e8a051142ecb65520dd19948cc56afae70f050a325b1aa1a50d2fbb5ddb8a2ecb2f8f3456a9fce97f8354c0054095b531f"
    },
    {
      "line": 208,
      "relation": "decreases",
      "evidence": "Epigallocatechin-3-gallate (EGCG), a small molecule that been shown to inhibit the aggregation of several amyloidogenic proteins such as a-syn, amyloid-beta and huntingtin [9, 37, 38, 105] binds to unfolded native amyloid-beta and a-syn and promotes the formation of nontoxic oligomers that do not convert into amyloid fibrils [37]. ",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true,
          "Brain": true,
          "Serum": true
        }
      },
      "source": 0,
      "target": 7,
      "key": "0ca7a857fcff5fc56d39eb417ea0921b66436634756c7dd3fceb2b13f8cbed43452adee6734fe063fa727ec3c011f984369764263d42f475411bf93a44526c44"
    },
    {
      "line": 213,
      "relation": "decreases",
      "evidence": "Prabhudesai et al. showed that this molecule is able to inhibit the aggregation of a-syn in vitro and in a zebrafish model expressing human wild-type a-syn in neurons where CLR01 reduced apoptosis and improved embryo survival [127]. ",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true,
          "Brain": true,
          "Serum": true
        }
      },
      "source": 11,
      "target": 6,
      "key": "68502d6fd6b4f8df8c62c9d8e47c4b8c942976756f74e298136e3f8d14f18bc8a2715443bd5bc38f51820a60d3bfeff8f9f6c6ba05e9748aa792abe0c3ce5eff"
    },
    {
      "line": 215,
      "relation": "decreases",
      "evidence": "Prabhudesai et al. showed that this molecule is able to inhibit the aggregation of a-syn in vitro and in a zebrafish model expressing human wild-type a-syn in neurons where CLR01 reduced apoptosis and improved embryo survival [127]. ",
      "citation": {
        "type": "PubMed",
        "reference": "28803412",
        "name": "Acta neuropathologica",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "volume": "134",
        "pages": "819-838",
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ]
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true,
          "Brain": true,
          "Serum": true
        },
        "Cell": {
          "neuron": true
        }
      },
      "source": 11,
      "target": 18,
      "key": "f01a10de7e1f69f3996ff9ef4c7443178513fd3d2aef3b1f8101229ebea7a0a25691080b33b5d3e6c193ceb32fcd89703df0586a3ae41d1a796debbd45869cf3"
    }
  ]
}